An FDA-cleared digital treatment for insomnia patients
SleepioRx is a digital treatment that teaches patients techniques rooted in cognitive-behavioral therapy (CBT), the first-line recommended treatment for insomnia.
Get StartedIn a clinical trial, 76% of SleepioRx patients experienced clinically significant improvements in insomnia
54%
reduction in time to fall asleep.1
62%
less time awake at night.1
45%
better functioning the next day.1
For the past decade, we’ve been putting SleepioRx to the test in gold-standard clinical trials.
22 clinical trials replicating effectiveness in improving insomnia and sleep outcomes
Peer-reviewed publications in JAMA Psychiatry, The Lancet, and SLEEP
Referenced in 4 US and international clinical guidelines, including NICE2
An effective tool for supporting your practice
SleepioRx enhances provider care plans by making CBT-I accessible on-demand. In 5 minutes or less, patients can learn techniques to help them quiet their racing minds, reshape behaviors, and resolve sleep troubles — available to them 24/7.
Immediate access to first-line care
When it’s needed the most, SleepioRx is instantly accessible and ready to check in, practice, or try a new technique. No waitlists required.
Non-drug option that patients prefer
SleepioRx targets the root cause of insomnia to deliver lasting results for the 75% of patients who say they’d prefer a non-drug option.3
Seamless, low-lift implementation
We make it easy for you to unlock access to care for patients through a simple and streamlined implementation process.
Related reading
1. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769-781.
2. Miller, C. B., Carl, J. R., Henry, A. L., Baker, L. (2020). A health economic evaluation of Sleepio at a Fortune 500 company. Retrieved from: https://go.bighealth.com/report/health-economic-evaluation. *This is a total estimate that is based on statistically significant and non-significant reductions in costs across categories; thus the exact figure would require confirmation in further research with a larger sample size.
SleepioRx is a digital therapeutic intended for the treatment of chronic insomnia/insomnia disorder as an adjunct to usual care in patients aged 18 and older. Sleepio is a prescription device delivering Cognitive Behavioral Therapy for Insomnia (CBT-I) and can be made available on the order of a licensed healthcare provider. Patients should read the indications for use.
DOC-3652 Effective Aug 2024